April 12, 2019
Kuopio combines a great business environment, strong international networks and a wide range of education and research expertise.
Published: April 12, 2019
Top stories
Collaboration – June 24, 2026
The agreement, building on a letter of intent announced earlier this year, is intended to establish a long-term partnership in spray-dried formulations, a technology considered important for the development of inhalable drug formulations for biologics, vaccines, and other large molecules.
Business article – June 24, 2026
A newly approved EUR 2.8 million project will, over the next three years, bring together leading organizations from Sweden, Denmark and Norway to accelerate commercialization, investment and market access for companies developing solutions in women’s health.
CDMO – June 24, 2026
Following the outcome of the DIAGNODE-3 study, the company’s immediate priority is to complete the close-out of the Phase 3 program in an efficient and responsible manner, it states.
Biotech Business – June 23, 2026
The partnership will leverage Combotope’s SMART-Phage platform to generate highly tumor-selective antibodies for next-generation cancer therapies.
This site uses cookies
